T1	Intervention 922 955	primary glaucoma triple procedure
T2	Intervention 765 921	receive either no adjunctive mitomycin C (101 eyes of 101 patients) or to receive adjunctive subconjunctival mitomycin C (96 eyes of 96 patients) during the
